Unlocking Translational Insights from Tempus Real-World Data with Genedata Profiler
Over the past years, Real-World Data (RWD) has become an important asset in the biopharma industry. However, due to its complexity and vast quantity, an effective translation of RWD into valuable evidence that can support clinical development strategies has proven challenging.
Do you want to learn how to efficiently work with RWD to extract knowledge and improve your clinical decision-making?
Our latest webinar demonstrates how a 20 top pharma company, Astellas Pharma leverages the Genedata Profiler platform to generate scientific insights from Tempus RWD in oncology translational research. During his presentation, Dr. Guoqiang Zhang, Associate Director of Translational Bioinformatics at Astellas, explains how our software supports seamless RWD exploration by providing:
- A powerful Data Inventory for improved data discoverability
- Scalable bioinformatics pipelines to process large amounts of molecular data in a standardized and reproducible manner
- Integrated development environment to enable rapid generation of data visualization applications
Who should watch?
Biopharma and biotech professionals working in translational research looking to unlock the value of RWD to inform clinical development strategies through enhanced data integration and analytics.
Speaker: Dr. Guoqiang Zhang, Associate Director of Translational Bioinformatics at Astellas